Lupin also launched quetiapine fumarate
extended-release tablets, 50 mg, 150 mg, 200 mg, 300 mg and 400 mg, the AB-rated generic equivalent of AstraZeneca Pharmaceuticals LP's Seroquel XR.
Development and validation of UV-Spectrophotometric method for determination of Quetiapine fumarate
in two different dose tablets.
Efficacy and tolerability of extended release quetiapine fumarate
(quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized study.
is an atypical antipsychotic medication FDA approved and used for the treatment of affective disorders and schizophrenia, and is used off-label in the management of several other psychiatric disorders.
The FDA's Psychopharmacologic Drugs Advisory Committee voted that quetiapine fumarate
(Seroquel XR) is safe as an adjunctive therapy for major depressive disorder and generalized anxiety disorder, but only in certain instances as a first-line therapy for MDD and not as a standalone treatment for GAD.
is safe as an adjunctive therapy for major depressive disorder and generalized anxiety disorder, according to a Food and Drug Administration panel.
State Hospital, did something he almost never has to do: In consultation with attending physicians, he switched 17 patients from one drug--the antipsychotic quetiapine fumarate
(Seroquel)--to other medications.
Long-term effects of quetiapine fumarate
in parkinsonism complicated by psychosis.
NSE: LUPIN), an Indian transnational pharmaceutical firm, has announced a deal with Astellas Pharma (TYO: 4503) that grants it the exclusive right to market the quetiapine fumarate
, an anti-depressant, in Japan.
The company launched: dipyridamole tablets, USP; quetiapine fumarate
tablets; tinidazole tablets; hydromorphone hydrochloride oral solution, USP; nevirapine oral suspension; montelukast sodium tablets; montelukast sodium chewable tablets; oxcarbazepine oral suspension; irbesartan and hydrochlorothiazide tablets, USP; and irebesartan tablets, USE
Pharmaceutical company Intellipharmaceutics International (NasdaqCM:IPCI) (TSX:I) reported on Friday the receipt of tentative approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for quetiapine fumarate
extended-release tablets in the 50, 150, 200, 300 and 400 mg strengths for use in the treatment of schizophrenia and bipolar disorder.
4 December 2009 - Anglo-Swedish pharma major AstraZeneca (LON:AZN) (STO:AZN) said Friday its once-daily anti-psychotic drug Seroquel XR, or quetiapine fumarate
extended-release tablets, has been approved as an add-on treatment to anti-depressants in adults with major depressive disorder (MDD) in the USA.